TY - JOUR
T1 - A mutation screen in patients with Kabuki syndrome
AU - Li, Yun
AU - Bögershausen, Nina
AU - Alanay, Yasemin
AU - Simsek Kiper, Pelin Özlem
AU - Plume, Nadine
AU - Keupp, Katharina
AU - Pohl, Esther
AU - Pawlik, Barbara
AU - Rachwalski, Martin
AU - Milz, Esther
AU - Thoenes, Michaela
AU - Albrecht, Beate
AU - Prott, Eva Christina
AU - Lehmkühler, Margret
AU - Demuth, Stephanie
AU - Utine, Gülen Eda
AU - Boduroglu, Koray
AU - Frankenbusch, Katja
AU - Borck, Guntram
AU - Gillessen-Kaesbach, Gabriele
AU - Yigit, Gökhan
AU - Wieczorek, Dagmar
AU - Wollnik, Bernd
PY - 2011/12/1
Y1 - 2011/12/1
N2 - Kabuki syndrome (KS) is one of the classical, clinically well-known multiple anomalies/mental retardation syndromes, mainly characterized by a very distinctive facial appearance in combination with additional clinical signs such as developmental delay, short stature, persistent fingerpads, and urogenital tract anomalies. In our study, we sequenced all 54 coding exons of the recently identified MLL2 gene in 34 patients with Kabuki syndrome. We identified 18 distinct mutations in 19 patients, 11 of 12 tested de novo. Mutations were located all over the gene and included three nonsense mutations, two splice-site mutations, six small deletions or insertions, and seven missense mutations. We compared frequencies of clinical symptoms in MLL2 mutation carriers versus non-carriers. MLL2 mutation carriers significantly more often presented with short stature and renal anomalies (p = 0.026 and 0.031, respectively), and in addition, MLL2 carriers obviously showed more frequently a typical facial gestalt (17/19) compared with non-carriers (9/15), although this result was not statistically significant (p = 0.1). Mutation-negative patients were subsequently tested for mutations in ten functional candidate genes (e.g. MLL, ASC2, ASH2L, and WDR5), but no convincing causative mutations could be found. Our results indicate that MLL2 is the major gene for Kabuki syndrome with a wide spectrum of de novo mutations and strongly suggest further genetic heterogeneity.
AB - Kabuki syndrome (KS) is one of the classical, clinically well-known multiple anomalies/mental retardation syndromes, mainly characterized by a very distinctive facial appearance in combination with additional clinical signs such as developmental delay, short stature, persistent fingerpads, and urogenital tract anomalies. In our study, we sequenced all 54 coding exons of the recently identified MLL2 gene in 34 patients with Kabuki syndrome. We identified 18 distinct mutations in 19 patients, 11 of 12 tested de novo. Mutations were located all over the gene and included three nonsense mutations, two splice-site mutations, six small deletions or insertions, and seven missense mutations. We compared frequencies of clinical symptoms in MLL2 mutation carriers versus non-carriers. MLL2 mutation carriers significantly more often presented with short stature and renal anomalies (p = 0.026 and 0.031, respectively), and in addition, MLL2 carriers obviously showed more frequently a typical facial gestalt (17/19) compared with non-carriers (9/15), although this result was not statistically significant (p = 0.1). Mutation-negative patients were subsequently tested for mutations in ten functional candidate genes (e.g. MLL, ASC2, ASH2L, and WDR5), but no convincing causative mutations could be found. Our results indicate that MLL2 is the major gene for Kabuki syndrome with a wide spectrum of de novo mutations and strongly suggest further genetic heterogeneity.
UR - http://www.scopus.com/inward/record.url?scp=82555194140&partnerID=8YFLogxK
U2 - 10.1007/s00439-011-1004-y
DO - 10.1007/s00439-011-1004-y
M3 - Journal articles
C2 - 21607748
AN - SCOPUS:82555194140
SN - 0340-6717
VL - 130
SP - 715
EP - 724
JO - Human Genetics
JF - Human Genetics
IS - 6
ER -